Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Chronic ProgressiveSclerosisAmyotrophic Lateral SclerosisEncephalomyelitis, Autoimmune, ExperimentalTuberous SclerosisDemyelinating DiseasesOptic NeuritisMyelin Basic ProteinMagnetic Resonance ImagingScleroderma, SystemicBrainOligoclonal BandsInterferon-betaMyelin SheathMyelin-Oligodendrocyte GlycoproteinSpinal CordDisability EvaluationMyelin ProteinsOligodendrogliaMyelin-Associated GlycoproteinNeuromyelitis OpticaDisease ProgressionCentral Nervous SystemMyelin Proteolipid ProteinAtrophyImmunologic FactorsHLA-DR2 AntigenEncephalomyelitis, Acute DisseminatedCuprizoneNerve Fibers, MyelinatedDiffuse Cerebral Sclerosis of SchilderCase-Control StudiesPropylene GlycolsDemyelinating Autoimmune Diseases, CNSDisease Models, AnimalTheilovirusSeverity of Illness IndexAxonsNervous System DiseasesRecurrenceAge of OnsetCerebrospinal FluidT-LymphocytesHLA-DRB1 ChainsCerebrospinal Fluid ProteinsMicrogliaOptic NerveAutoimmune DiseasesCardiovirus InfectionsNeurologic ExaminationRemission, SpontaneousFatigueAutoimmunityMice, Inbred C57BLBlood-Brain BarrierImmunosuppressive AgentsAstrocytesMethylprednisoloneEvoked Potentials, VisualAutoantibodiesScleroderma, DiffuseImmunoglobulin GHLA-DR AntigensTime FactorsGenetic Predisposition to DiseaseFollow-Up StudiesGadoliniumNeuritisAutoantigensNerve DegenerationMyelitis, TransverseImage EnhancementDisabled PersonsInflammationCentral Nervous System DiseasesCells, CulturedReproducibility of ResultsStatistics, NonparametricCorpus CallosumAdjuvants, ImmunologicCytokinesSpinal Cord DiseasesCohort StudiesMotor Neuron DiseaseScleroderma, LimitedEncephalomyelitisBiological MarkersSubacute Sclerosing PanencephalitisImage Processing, Computer-AssistedNeurofilament ProteinsRats, Inbred LewPeptidesTreatment OutcomeMeningesCD4-Positive T-LymphocytesLymphocyte ActivationCognition DisordersEncephalitis